保密 | 投資責任聲明 | 聯繫我們
Excorp Medical's Bioartificial Liver System comprises a reusable instrument, disposable tubing set and the proprietary, disposable bioartificail reactor.Once approved by regulatory agencies, Excorp Medical expects this breakthrough Bioartificial Liver System technology to be both live-saving and cost effective.Certain drugs or machines are available to substitute temporarily or long-term for many organs in the body…  no comparable substitute has been developed for the liver.The liver is the largest organ in the body and performs a variety of tasks impacting all body systems… as a result liver disease has widespread effects on virtually all other organs.Excorp Medical is currently the only company approved to conduct bioartificial liver human trials within the U.S.Currently patients must receive a liver transplant or endure prolonged hospitalization at great expense to have a chance at survival.Excorp Medical Bioartificial Liver System treatments serve as a bridge to liver regeneration and transplantExcorp Medical has developed a Bioartificial Liver System for the metabolic support of patients with compromised liver function.
Chinese Simplified
简体中文
Chinese Traditional
繁體中文
Arabic

聯繫方式：
新聞
關聯單位
出版文章
臨床研究
招聘
致投資者
Send us an email 請發送郵件至：info@excorp.com

請發送信件至：
美國明尼蘇達州明尼阿普利斯市卡蘇達大街739 號，愛克思科醫療設備
有限公司收，郵遞區號：55414

請致電至：
651.484.0042 (美國境內)
001.651.484.0042 (美國境外)

請發傳真至：
651.484.0042 (美國境內)
001.651.484.0042 (美國境外)
愛克思科醫療設備有限公司將出席2009 年3 月19－20 日舉行的中國生物（ChinaBio®）投資者論 壇。公司已獲准入駐香港科學園，並已發出2009 年第1 季度《股東通訊》。
©2014 Excorp Medical, Inc.